Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Masahiro Kuno
Institutions:
The Cancer Institute Hospital,
Toranomon Hospital,
Japanese Foundation For Cancer Research
Observed institutions:
Keio University,
The Cancer Institute Hospital,
Toranomon Hospital,
Japanese Foundation For Cancer Research
ORCID:
0009-0005-7328-6729
Observed ORCID:
0009-0005-7328-6729
OpenAlex ID:
A5148960184
Artificial Intelligence in Clinical Oncology: From Productivity Enhancement to Creative Discovery
2025
·
Masahiro Kuno
, Hiroki Osumi
, et al.
·
Current Oncology
·
9
PDF
Medical AI and AI for Medical Sciences
2025
·
Kazuhiro Sakurada
, Tetsuo Ishikawa
, et al.
·
JMA Journal
·
9
Risk factors and long-term prognostic impact of trastuzumab deruxtecan-related interstitial lung disease in metastatic breast cancer.
2026
·
Takayuki Kobayashi
, Meiko Nishimura
, et al.
·
Journal of Clinical Oncology
·
1
Time to maximal response of trastuzumab deruxtecan in patients with HER2-Positive metastatic breast cancer: A multicenter retrospective study (TRACE)
2026
·
Yukinori Ozaki
, Emi Taniguchi
, et al.
·
The Breast
S-1 versus capecitabine as first-line chemotherapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer in the era of cyclin-dependent kinase 4/6 inhibitors: a retrospective cohort study
2026
·
Takayuki Kobayashi
, Meiko Nishimura
, et al.
·
BMC Cancer
Real-world event-free survival with neoadjuvant pembrolizumab plus chemotherapy and adjuvant pembrolizumab in early-stage triple-negative and estrogen receptor-low, HER2-negative breast cancer
2026
·
Yosuke Aoyama
, Yukinori Ozaki
, et al.
·
BMC Cancer
Real-world outcomes of datopotamab deruxtecan after trastuzumab deruxtecan in hormone receptor–positive, HER2-negative metastatic breast cancer
2026
·
Yosuke Aoyama
, Yukinori Ozaki
, et al.
·
Breast Cancer
PDF
Sex differences in chemotherapy-induced alopecia distress using the Japanese version of the Chemotherapy-Induced Alopecia Distress Scale
2026
·
Hiroki Okumura
, Shuko Soma
, et al.
·
Supportive Care in Cancer
Prospective study of a novel portable scalp-cooling cap for prevention of chemotherapy-induced alopecia.
2026
·
Yosuke Aoyama
, Takehiko Sakai
, et al.
·
Journal of Clinical Oncology
Efficacy of datopotamab deruxtecan after trastuzumab deruxtecan in metastatic hormone receptor–positive HER2-negative breast cancer: A real-world study.
2026
·
Yosuke Aoyama
, Yukinori Ozaki
, et al.
·
Journal of Clinical Oncology
PDF
Prognostic impact of RAS/BRAF mutations and clinical factors in 441 patients undergoing pulmonary metastasectomy for colorectal cancer.
2026
·
Masahiro Kuno
, Hiroki Osumi
, et al.
·
Journal of Clinical Oncology
PDF
Real-world pathological outcomes after neoadjuvant chemotherapy with subcutaneous versus intravenous pertuzumab and trastuzumab in HER2-positive early breast cancer
2026
·
Haruka Ozaki
, Jun Masuda
, et al.
·
SSRN Electronic Journal
PDF
Show more works
View as search
Works count:
12
Citation count:
19
H-index:
2
I10-index:
Year
Topic
Type